C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2006
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257924 Process for the isolation of the extrachromosomal DNA and method for the diagnosis based on the electrophoretic analysis of such DNA
11/16/2006	US20060257922 Methods to detect cross-contamination between samples contacted with a multi-array substrate
11/16/2006	US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI
11/16/2006	US20060257920 Substrate coated with trialkoxysilylaminoalkyleneamine methylated, acetylated or overmethylated to produce phosphate-reactive ammonium ions; water contact angle of >46 degrees; immobilize nucleic acid probes onto microwell plates for in hybridization assays; better retention, signal intensity, stability
11/16/2006	US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006	US20060257917 Fluorescent dyes, energy transfer couples and methods
11/16/2006	US20060257916 Testing of an organism and correlating the results with a unique marker (single nucleotide polymorphism or short tandem repeats) that identifies the sample; contacting a target sequence with oligonucleotide probes, interrogating the hybridization complexes, decoding
11/16/2006	US20060257915 Methods of producing competitive aptamer fret reagents and assays
11/16/2006	US20060257914 Methods of producing interachain fluorophore-quencher FRET-aptamers and assays
11/16/2006	US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof
11/16/2006	US20060257912 Methods and sequences to suppress primate huntington gene expression
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257910 aligning a protein on a surface; immobilization; Preparing solid support comprising immobilized proteins for detecting, measuring, separating and/or assaying DNA or proteins in a sample
11/16/2006	US20060257909 Methods for reducing the percentage of abnormal gametes
11/16/2006	US20060257908 Method for two- and three-dimensional microassembly of patterns and structures
11/16/2006	US20060257907 Packed bed for nucleic acid capture and amplification
11/16/2006	US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses
11/16/2006	US20060257905 using a DNA methylation-maintenance enzyme and a DNA polymerase with strand displacement activity, in the presence of buffers comprising magnesium chloride or sulfate, deoxynucleotide triphosphates, genetic primers and S-adenosyl-methionine
11/16/2006	US20060257904 Agglomeration protein cascades, compositions and methods regarding the same
11/16/2006	US20060257903 Compositions and methods for diagnosing and treating neuropsychiatric disorders
11/16/2006	US20060257902 Methods and compositions for depleting abundant RNA transcripts
11/16/2006	US20060257901 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
11/16/2006	US20060257900 Method for the discovery of high-affinity, high specificity oligonucleotide and derivatized oligonucleotide sequences for target recognition
11/16/2006	US20060257899 Methods and Apparatus for Controlling DNA Amplification
11/16/2006	US20060257898 Comparing the level of RNA for isoform 2 of subunit 4 of cytochrome c oxidase in a sample of lung cells with a sample of lung cells that are known not to have cancer; a lower level of the oxidase in the cells indicates the presence of cancer
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006	US20060257896 Splice variants, polynucleotide biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer
11/16/2006	US20060257895 Detection of chromosomal abnormalities associated with breast cancer
11/16/2006	US20060257894 Molecular typing of listeria monocytogenes, hybridization supports and kits for said molecular typing
11/16/2006	US20060257893 Devices and methods for monitoring genomic DNA of organisms
11/16/2006	US20060257892 Methods and compositions for treating a subject having an anthrax toxin mediated condition
11/16/2006	US20060257891 Method for effecting the rapid release of a signature chemical from bacterial endospores, and for detection thereof
11/16/2006	US20060257889 Ribonuclease resistant RNA preparation and utilization
11/16/2006	US20060257888 Genetic diagnosis using multiple sequence variant analysis
11/16/2006	US20060257887 Protein -protein interaction detection system using fluorescent protein microdomains
11/16/2006	US20060257886 Method for analyzing molecular fluorescence using evanescent illumination
11/16/2006	US20060257885 Homogeneous assay system
11/16/2006	US20060257884 Methods for preparing and analyzing cells having chromosomal abnormalities
11/16/2006	US20060257883 Detection and measurement of hematological parameters characterizing cellular blood components
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257881 Oligonucleotides for detecting male infertility
11/16/2006	US20060257880 Gastric and prostate cancer associated antigens
11/16/2006	US20060257879 Methods and kits for detecting an enzyme capable of modifying a nucleic acid
11/16/2006	US20060257878 Nucleic acid amplifier and method of nucleic acid amplification
11/16/2006	US20060257877 Method for the validatable inactivation of pathogens in a biological fluid by irradiation
11/16/2006	US20060257876 Polymerase-based protocols for generating chimeric and combinatorial...
11/16/2006	US20060257874 Method for determining the amount of template nucleic acid present in a sample
11/16/2006	US20060257873 Chemical switching of nucleic acid circuit elements
11/16/2006	US20060257872 Cell lines and host nucleic acid sequences related to infectious disease
11/16/2006	US20060257871 One step real-time rt pcr kits for the universal detection of organisms in industrial products
11/16/2006	US20060257870 Cdkl 1 as modifier of branching morphogenesis and methods of use
11/16/2006	US20060257869 for stimulation of angiogenesis
11/16/2006	US20060257868 Tissue specific genes and gene clusters
11/16/2006	US20060257867 Ghrelin binding nucleic acids
11/16/2006	US20060257866 Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay
11/16/2006	US20060257865 Method for identification and development of therapeutic agents
11/16/2006	US20060257864 Primers designed on basis of the difference of sequences among staphylococcal enterotoxin subtypes
11/16/2006	US20060257863 Viral detection method using viral encoded enzymes and chemiluminescent substrates
11/16/2006	US20060257862 A highly cost-effective analytical device for performing immunoassays with ultra high sensitivity
11/16/2006	US20060257861 Screening assay for inhibitors of severe acute respiratory syndrome (SARS) using SELDI-TOF Mass Spectrometry
11/16/2006	US20060257860 Compositions and assays to detect influenza virus A and B nucleic acids
11/16/2006	US20060257859 Recombinant enterovirus 71 neutralizing antibodies and applications thereof
11/16/2006	US20060257858 Methods and compositions for introducing biopolymers into cells
11/16/2006	US20060257857 Methods for identifying functionally related genes and drug targets
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257855 Biological particulate matter analogue
11/16/2006	US20060257854 Membrane assay system including preloaded particles
11/16/2006	US20060257853 Autonomous surveillance system
11/16/2006	US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006	US20060257851 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
11/16/2006	US20060257850 Methods of treatment and diagnosis of patients with hepatitis c infection
11/16/2006	US20060257849 Method of screening for therapeutics for infectious diseases
11/16/2006	US20060257848 Contacting cell which lacks Type I phosphatidylinositol phosphate kinase isoform gamma 661 (PIPKI gamma 661) with a test agent and measuring the adherence of cell to a surface
11/16/2006	US20060257847 replaces internal magnetic capture structure with small V-shaped grooves on the fluid side of the optically transparent (viewing) face of the chamber, and with the optimum dilution of magnetically-labeled specimens provides an alignment surface for automated optical analysis; automated cell enumeration
11/16/2006	US20060257846 Method of assaying for high performance mammals
11/16/2006	US20060257845 Cosmetic treatment of xerosis
11/16/2006	US20060257844 Disinfection of biological fluids using asymmetric cyanine dyes
11/16/2006	US20060257429 Vaccine for periodontal disease
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257409 Breast Specific Genes and Proteins
11/16/2006	US20060257408 Method for influencing kinase pathways with IL-22
11/16/2006	US20060257405 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)
11/16/2006	US20060257389 Diagnosis of blood clots using fibrin-binding proteins bound with contrast agents
11/16/2006	US20060257387 Sugar chain synthase gene
11/16/2006	US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	US20060256340 Method and a system for determination of particles in a liquid sample
11/16/2006	US20060254932 Electrochemical cell
11/16/2006	US20060254910 P channel filed effect transistor and sensor using the same
11/16/2006	US20060254909 Electrode and sensor using same
11/16/2006	DE202006009728U1 Microarray assembly includes microporous membrane having different analyte-specific capture molecules (proteins, antibodies or nucleic acids), and incubation chamber arrangement
11/16/2006	DE102005023055A1 Making DNA fragments for determining DNA methylation pattern involves digesting DNA with methylation-specific restriction enzyme; and ligating adapters to restriction fragments, followed by primer mediated-amplification of ligated fragments
11/16/2006	DE102005022145A1 Nucleic acid-binding chip, useful for determining the physiological status of an organism, particularly detecting glucose deficiency in fermentations, carries probes for specified genes
11/16/2006	DE102005021205A1 Detection of vitality of living cells in cell culture or tissue by nicotinamide adenine dinucleotide hydrogenase fluorescence spectroscopy, comprises irradiating the cells by short periodically produced light pulses in the near ultraviolet
11/16/2006	DE10010282B4 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples
11/16/2006	CA2651376A1 Method for diagnosis and treatment of a mental disease
11/16/2006	CA2651367A1 Methods of enriching fetal cells

1 ... 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 ... 3003